Skip to main content
. 2022 Aug 17;17:143. doi: 10.1186/s13014-022-02117-z

Table 2.

Associations between investigated factors and post-treatment ambulatory status

Factor Subgroup (n) Ambulatory after treatment, n (%) p value
Age  ≤ 65 years (275) 71 (26) 0.90
 > 65 years (270) 71 (26)
Interval FD to MSCC  ≤ 15 months (383) 99 (26) 0.87
 > 15 months (162) 43 (27)
Visceral metastases No (114) 29 (25) 0.87
Yes (431) 113 (26)
Further bone metastases No (126) 35 (28) 0.62
Yes (419) 107 (26)
Primary tumor type Breast cancer (57) 16 (28) < 0.001
Prostate cancer (74) 9 (12)
Myeloma/lymphoma (24) 13 (54)
Lung cancer (175) 54 (31)
Other malignancies (215) 50 (23)
Sex Female (170) 48 (28) 0.43
Male (375) 94 (25)
Time developing motor deficits 0–7 days (309) 40 (13) < 0.0001
8–14 days (122) 39 (32)
 > 14 days (114) 63 (55)
Ambulatory prior to radiotherapy No (375) 24 (6) < 0.0001
Yes (170) 118 (69)
Number of affected vertebrae 1–2 (192) 70 (36) < 0.0001
 ≥ 3 (353) 72 (20)
Radiotherapy regimen 1 × 8 Gy/5 × 4 Gy (239) 9 (16) 0.40
5 × 5 Gy/longer-course RT (306) 133 (27)
Entire cohort N = 545 142 (26)

FD First diagnosis of malignancy, MSCC Metastatic spinal cord compression, RT Radiotherapy

p values were calculated with the Chi-square test. When applying Bonferroni adjustment, p values of < 0.005 were considered significant and are given in bold